Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants

2.1K

Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.1K
Autonomic Nervous System01:22

Autonomic Nervous System

13.0K
The autonomic nervous system (ANS) is a critical component of the peripheral nervous system, primarily responsible for regulating involuntary bodily functions and maintaining homeostasis. It functions in tandem with the central nervous system (CNS) to seamlessly coordinate various physiological processes without the need for conscious control.
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
13.0K
Autonomic Nervous System: Overview01:26

Autonomic Nervous System: Overview

7.6K
The human nervous system is divided into two main parts: the central nervous system (CNS) and the peripheral nervous system (PNS). The CNS is composed of the brain and spinal cord, while the PNS contains nerve cells, clusters of nerve cells, and the sensory receptors that are outside the CNS. The PNS has two types of nerve cells: sensory (afferent) and motor (efferent). Sensory cells send signals to the CNS from receptors, and motor cells carry signals from the CNS to organs, muscles, and...
7.6K
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

1.6K
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
1.6K
Drugs Acting on Autonomic Ganglia: Blockers01:28

Drugs Acting on Autonomic Ganglia: Blockers

1.7K
Ganglionic blockers inhibit autonomic activity by blocking nicotinic receptors in the autonomic ganglia, suppressing impulse transmission. These blockers lack selectivity between sympathetic and parasympathetic ganglia and are ineffective as neuromuscular junction antagonists. They can be categorized into two groups:
1.7K
Stimulants01:29

Stimulants

1.0K
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical Options for Cranial Nerve Functional Diseases.

Advances and technical standards in neurosurgery·2026
Same author

Comparison of neuropsychological side effects between contemporary radiofrequency ablative neurosurgery for psychiatric disorders and conventional neurosurgical procedures: systematic review and meta-analysis.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Introduction. Vascular compression syndromes and their management.

Neurosurgical focus·2025
Same author

In Reply: The Use of a 405-nm Blue Light System in a Neurosurgical Department as an Adjunct for Lowering Environmental Contamination and Perioperative Infections: Results From a Prospective Observational Cohort Study.

Neurosurgery·2025
Same author

The Use of a 405-nm Blue Light System in a Neurosurgical Department as an Adjunct for Lowering Environmental Contamination and Perioperative Infections: Results from a Prospective Observational Cohort Study.

Neurosurgery·2025
Same author

New horizons for adolescent idiopathic scoliosis treatment through PosturalSpine<sup>®</sup> D'Amanti Method.

European journal of translational myology·2025

Related Experiment Video

Updated: Feb 11, 2026

Deep Brain Stimulation with Simultaneous fMRI in Rodents
11:09

Deep Brain Stimulation with Simultaneous fMRI in Rodents

Published on: February 15, 2014

14.6K

Deep brain stimulation for trigeminal autonomic cephalalgias.

Giuseppe Messina1, Giovanni Broggi1,2, Vincenzo Levi1

  • 1Functional Neurosurgery Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Expert Review of Neurotherapeutics
|April 20, 2018
PubMed
Summary

Deep brain stimulation (DBS) targeting the posterior hypothalamic region (pHyr) offers relief for trigeminal autonomic cephalalgias (TACs). Understanding the precise stimulation site and mechanisms is key to improving outcomes for refractory patients.

Keywords:
Hypothalamusdeep brain stimulationheadacheneurophysiologytrigeminal autonomic cephalalgias

More Related Videos

Using Saccadometry with Deep Brain Stimulation to Study Normal and Pathological Brain Function
05:44

Using Saccadometry with Deep Brain Stimulation to Study Normal and Pathological Brain Function

Published on: July 14, 2016

7.9K
Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain
09:35

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain

Published on: May 10, 2017

19.6K

Related Experiment Videos

Last Updated: Feb 11, 2026

Deep Brain Stimulation with Simultaneous fMRI in Rodents
11:09

Deep Brain Stimulation with Simultaneous fMRI in Rodents

Published on: February 15, 2014

14.6K
Using Saccadometry with Deep Brain Stimulation to Study Normal and Pathological Brain Function
05:44

Using Saccadometry with Deep Brain Stimulation to Study Normal and Pathological Brain Function

Published on: July 14, 2016

7.9K
Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain
09:35

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain

Published on: May 10, 2017

19.6K

Area of Science:

  • Neurology
  • Neurosurgery
  • Pain Medicine

Background:

  • Deep brain stimulation (DBS) of the posterior hypothalamic region (pHyr) is an established treatment for trigeminal autonomic cephalalgias (TACs).
  • Significant patient variability in response and ongoing debate regarding optimal stimulation targets and mechanisms persist.
  • TACs represent severe, life-threatening headache disorders requiring effective therapeutic strategies.

Purpose of the Study:

  • To review current literature on DBS for TACs, focusing on recent advancements and critical factors for patient management.
  • To explore the functional anatomy of the hypothalamus, experimental data, and pathophysiological hypotheses related to TACs.
  • To address the challenges in identifying the precise therapeutic target and improving outcomes for refractory cases.

Main Methods:

  • Comprehensive literature review of recent studies on DBS for TACs.
  • Analysis of hypothalamic functional anatomy and neurophysiological data.
  • Examination of experimental models and pathophysiological hypotheses.

Main Results:

  • Approximately 32% of patients treated with DBS for TACs achieve pain freedom.
  • The posterior hypothalamic region (pHyr) appears critical for pain attack generation in TACs.
  • Complex interactions with other neural structures are involved in TACs pathophysiology.

Conclusions:

  • Precise targeting of the pHyr is crucial for effective DBS in TACs.
  • Further neurophysiological research and advanced experimental models are essential for understanding mechanisms.
  • Improved understanding is needed to overcome refractoriness and optimize treatment for TACs patients.